What to Know About the New Nasal Spray for Tough Depression …
1 day ago · A study by Johnson & Johnson, the company that makes Spravato, showed that 22.5% of people using esketamine nasal spray achieved remission from major depression in …
Spravato Nasal Spray Can Now Be Used Alone for Treatment …
1 day ago · The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment …
FDA approves first-of-its-kind nasal spray for severe depression
Jan 22, 2025 · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive …
FDA Approves Nasal Spray for Depression - Newsweek
Jan 22, 2025 · This new treatment could help bring relief for millions of Americans struggling with depression. What To Know. The nasal spray Spravato, which is made from the drug …
FDA allows standalone use of nasal spray antidepressant Spravato ...
Jan 21, 2025 · The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for …
FDA Approves Esketamine as First Monotherapy for Treatment …
Jan 21, 2025 · The US Food and Drug Administration (FDA) approved esketamine (SPRAVATO) CIII nasal spray as the first monotherapy for adults with treatment-resistant depression (TRD), …
SPRAVATO® (esketamine): A Prescription Nasal Spray
SPRAVATO®, the only FDA-approved nasal spray for adults with treatment-resistant depression, reduces depression symptoms when two or more oral antidepressants haven't worked. …
Spravato Nasal Spray: Uses, Dosage, Side Effects - Drugs.com
Aug 23, 2023 · Spravato (esketamine) nasal spray is used for treatment-resistant depression and major depressive disorder (MDD) with acute suicidal ideation or behavior. Includes Spravato …
FDA approves new nasal spray medication for treatment-resistant ...
The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have …
Esketamine for Treatment-Resistant Depression - Johns Hopkins Medicine
But it wasn’t until recently that esketamine, a more potent version of ketamine, earned FDA approval specifically for use as a nasal spray for those with treatment-resistant depression. …